PubRank

N Gitlin

Author PubWeight™ 26.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Extended lamivudine retreatment for chronic hepatitis B: maintenance of viral suppression after discontinuation of therapy. Hepatology 1999 2.64
2 Hepatitis C: risk of a haircut. Ann Intern Med 1997 1.39
3 d-Lactic acidosis due to abnormal gut flora: diagnosis and treatment of two cases. N Engl J Med 1982 1.35
4 The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol 1986 1.16
5 Immune-complex disease of the kidney associated with chronic hepatitis and cryoglobulinaemia. Lancet 1969 1.06
6 Amebic liver abscess. Annu Rev Med 1981 1.06
7 Factitious hyperamylasuria: a trap in the diagnosis of pancreatitis. N Engl J Med 1982 1.05
8 Splenic blood flow and resistance in patients with cirrhosis before and after portacaval anastomoses. Gastroenterology 1970 1.04
9 The pH of ascitic fluid in the diagnosis of spontaneous bacterial peritonitis in alcoholic cirrhosis. Hepatology 1982 0.98
10 Pericarditis--an extraintestinal complication of inflammatory bowel disease. West J Med 1990 0.90
11 Misoprostol in the treatment of duodenal ulcer refractory to H2-blocker therapy. A placebo-controlled, multicenter, double-blind, randomized trial. Am J Med 1987 0.89
12 A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal and twice-a-day famotidine in the treatment of active duodenal ulcer disease. Gastroenterology 1987 0.83
13 The clinical presentation of Gilbert's disease in 26 patients. S Afr Med J 1977 0.83
14 Perhexiline maleate in the management of patients with angina pectoris. A long-term assessment. S Afr Med J 1974 0.83
15 Zieve's syndrome and porphyrinuria in an alcoholic. Br Med J 1969 0.82
16 Spontaneous rupture of a bile duct and its endoscopic management in a patient with Caroli's syndrome. Am J Gastroenterol 1997 0.82
17 Pleural effusion associated with cirrhosis. S Afr Med J 1966 0.80
18 Progressive systemic sclerosis (diffuse scleroderma). A follow-up report of treatment with potaba. S Afr Med J 1973 0.79
19 Hepatic artery angiography in portal hypertension. Am J Med 1970 0.79
20 Raised serum transaminase levels in patients with rheumatic fever treated with salicylates. S Afr Med J 1977 0.77
21 The serum glutamic oxaloacetic transaminase/serum glutamic pyruvic transaminase ratio as a prognostic index in severe acute viral hepatitis. Am J Gastroenterol 1982 0.76
22 TIPS for patients with refractory hepatic hydrothorax: what is the take-home message? Am J Gastroenterol 1997 0.76
23 Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C. Aliment Pharmacol Ther 2007 0.76
24 Subclinical hepatic encephalopathy: how best to diagnose? Am J Gastroenterol 1997 0.76
25 Recurrent spontaneous infected pleural effusion in a patient with alcoholic cirrhosis, hepatic hydrothorax, and ascites. West J Med 1988 0.75
26 Fulminant neonatal hepatic necrosis associated with echovirus type 11 infection. West J Med 1983 0.75
27 Response to: Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage. Int J Clin Pract 2006 0.75
28 Hepatic arteriography. S Afr Med J 1972 0.75
29 alpha-Fetoprotein in liver disease. S Afr Med J 1978 0.75
30 Famotidine once-a-day in the management of duodenal ulcer: the U.S. placebo-controlled experience. J Clin Gastroenterol 1987 0.75
31 Acute hepatitis A: what's new with it? Am J Gastroenterol 1998 0.75
32 The management of ascites in patients with cirrhosis of the liver. S Afr Med J 1970 0.75
33 Severe recurrent hepatic encephalopathy that responded to oral branched chain amino acids. Am J Gastroenterol 1996 0.75
34 The anti-arrhythmic effects of perhexiline maleate in patients with ischaemic heart disease. S Afr Med J 1975 0.75
35 The incidence of Australia antigen-antibody in acute and chronic liver disease. S Afr Med J 1971 0.75
36 Liver dysfunction in ovarian hyperstimulation syndrome. A case report. J Reprod Med 1988 0.75
37 Flapping tremor associated with administration of diphenylhydantoin sodium. S Afr Med J 1976 0.75
38 Why do we need a newer generation of recombinant vaccines against hepatitis B? Am J Gastroenterol 1997 0.75
39 Patterns of hepatic injury induced by methyldopa. S Afr Med J 1979 0.75
40 The antistreptolysin titre (ASO titre) as a diagnostic index in hepatitis. S Afr Med J 1971 0.75
41 The investigation and natural history of acute viral hepatitis. S Afr Med J 1973 0.75
42 Thrombocytopenia associated with hepatitis C: is it real? Am J Gastroenterol 1997 0.75
43 Radiology in portal hypertension. S Afr Med J 1970 0.75
44 Treatments for hepatitis C: refinements in the recipe? Am J Gastroenterol 1995 0.75
45 Role of hepatic iron index in the management of iron overload syndromes in 1990's. Am J Gastroenterol 1998 0.75
46 Carbon tetrachloride-induced cirrhosis? S Afr Med J 1980 0.75
47 Cimetidine-induced hemolytic anemia: the fallacy of clinical associations. J Clin Gastroenterol 1983 0.75
48 Management of umbilical hernia associated with ascites. Am J Gastroenterol 1983 0.75
49 Omeprazole versus placebo in duodenal ulcer healing. The United States experience. Dig Dis Sci 1990 0.75
50 Splenic blood flow and resistance in patients with cirrhosis before and after portacaval anastomosis. Gut 1969 0.75
51 Proceedings: A long-term assessment of perhexiline maleate in the management of patients with angina pectoris. Postgrad Med J 1973 0.75
52 Alpha methyldopa and haemolytic anaemia. S Afr Med J 1973 0.75
53 Salicylate hepatitis. A case report. S Afr Med J 1974 0.75
54 Propranolol: its role in the management of portal hypertension. The ACG Committee on FDA related matters. Am J Gastroenterol 1983 0.75
55 Proceedings: Perhexiline maleate in the treatment of angina pectoris: a double-blind trial. Postgrad Med J 1973 0.75
56 Salicylate hepatotoxicity: the potential role of hypoalbuminemia. J Clin Gastroenterol 1980 0.75